ArticleRespiratory research2026
Decoding the ubiquitination-immunity axis in idiopathic pulmonary fibrosis: diagnostic insights and therapeutic implications.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundIdiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with limited therapeutic options. Emerging evidence suggests that ubiquitination-related genes (URGs) may contribute to IPF pathogenesis, although their diagnostic and immunological significance remains poorly understood.
methodsThree bulk RNA sequencing (RNA-seq) datasets (GSE110147, GSE53845, and GSE32537) and one single-cell RNA-seq dataset (GSE122960) were obtained from the Gene Expression Omnibus database. GSE110147 and GSE53845 were merged as the training cohort to construct a URG-based diagnostic model using least absolute shrinkage and selection operator (LASSO) regression, while GSE32537 and GSE122960 served as external validation cohorts. Immune cell infiltration was assessed using the CIBERSORT algorithm. A bleomycin-induced mouse model of pulmonary fibrosis was used to validate hub URG expression. The pro-fibrotic role of ubiquitin D (UBD) was evaluated in vitro using Cell Counting Kit-8 (CCK-8), wound healing, and transwell assays in mouse primary lung fibroblasts (PLFs). Transwell-based neutrophil migration assays were used to assess the impact of UBD expression in PLFs on neutrophil infiltration.
resultsWe developed a robust six-gene diagnostic signature with high predictive accuracy in both training and validation cohorts. Immune infiltration analysis revealed strong correlations between hub URGs and specific immune cell types. Among them, UBD showed the most significant upregulation in fibrotic lungs and was positively associated with neutrophil infiltration. Functional assays demonstrated that UBD silencing attenuated transforming growth factor β1 (TGFβ1)-induced fibroblast activation. Moreover, UBD knockdown significantly increased the expression levels of Cxcl2 and Cxcl3 in PLFs and promoted neutrophil migration.
conclusionThis study highlights the diagnostic and immunological relevance of URGs in IPF and identifies UBD as a key pro-fibrotic factor and neutrophil infiltration regulator, offering novel insights into IPF pathogenesis and potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.